National Institutes of Health
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development is a funding opportunity from National Institutes of Health, closing June 16, 2027.
Overview
The NIH Blueprint for Neuroscience Research is interested in continuing to support the BluePrint Neurotherapeutics Network for Small Molecules (BPN-SM)- a program designed to help investigators advance promising small-molecule therapeutics toward clinical testing. The BPN-SM program supports drug discovery and…